Joachim Baumgart

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 147 citations · Full text

DNA alkylation and interstrand cross-linking by treosulfan

John A. Hartley, C. Caroline O’Hare, Joachim Baumgart · British Journal of Cancer · 1998 · 117 citations · Full text

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.

A. Korfel, M. E. Scheulen, Hans‐Joachim Schmoll et al. · PubMed · 1998 · 113 citations

Nuclear Medicine, Oncology, Titanocene Dichloride +15

Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.

M. E. Scheulen, Ralf A. Hilger, C. Oberhoff et al. · PubMed · 2000 · 110 citations

Cell Therapy, Pathology, Pharmacotherapy +18

Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.

Constantina Christodoulou, D. Ferry, D. Fyfe et al. · Journal of Clinical Oncology · 1998 · 105 citations